Delve Bio

Test once. Know.

San Francisco, United States · Founded 2022

Employees
11–50
Founded
2022
Business Model
B2B
Website
delve.bio
Last Round
Series AJun 2023
Rounds
1

About

Delve Bio is a clinical diagnostics company on a mission to revolutionize infectious disease testing by bringing metagenomic next-generation sequencing (mNGS) testing out of the research lab and into the clinic. Founded by leading experts in infectious disease, Delve Bio's platform enables clinicians to test once and know — ending the era of sequential, time-consuming guess-and-test diagnostics. The company's Delve Detect product connects clinicians with medical experts for clinical consults and result interpretation, leveraging mNGS to identify pathogens across a broad range of infectious diseases in a single test.

Summary

Delve Bio is a Biotech company based in San Francisco, United States, founded in 2022. Its most recent funding was a Series A round in Jun 2023. Investors include Perceptive Advisors, GV and Section 32.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2023

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Delve Bio on Indexed.vc
<a href="https://indexed.vc/companies/delve-bio"><img src="https://indexed.vc/api/badge/company/delve-bio" alt="Delve Bio on Indexed.vc" width="260" height="76" /></a>